GO:0140973 positive regulation of AIM2 inflammasome complex assembly: Inflammasome Activation Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0140973 describes any process that activates or increases the frequency, rate or extent of AIM2 inflammasome complex assembly.
• The AIM2 inflammasome is a cytosolic innate immune platform that detects double-stranded DNA and triggers IL-1beta and IL-18 maturation and pyroptotic cell death.
• Positive regulation of AIM2 inflammasome assembly is critical for host defense against intracellular pathogens and for immune surveillance of tumors.
• Dysregulated AIM2 inflammasome activation contributes to inflammatory diseases, autoimmunity, and cancer progression.
• NCF4 has been identified as a negative regulator of inflammasome activation, highlighting the importance of tight control over AIM2 complex assembly.
• Immune complexes can inhibit IL-1 secretion and inflammasome activation, demonstrating that extracellular signals can modulate AIM2-dependent pathways.
Description
The AIM2 inflammasome is a multiprotein cytosolic complex that assembles in response to double-stranded DNA (dsDNA) and serves as a central effector of innate immunity. The Gene Ontology term GO:0140973, positive regulation of AIM2 inflammasome complex assembly, captures the regulatory processes that enhance the formation of this complex. Understanding this term is essential because AIM2 inflammasome assembly must be tightly controlled to mount effective antimicrobial and antitumor responses while avoiding excessive inflammation. Recent studies have shown that AIM2 inflammasome activation is modulated by a variety of cellular factors, including NCF4, which attenuates inflammasome activation and immune surveillance in colorectal cancer. Additionally, immune complexes have been found to inhibit IL-1 secretion and inflammasome activation, revealing that extracellular cues can suppress AIM2-dependent pathways. These findings underscore the importance of positive regulation of AIM2 inflammasome assembly in health and disease.
positive regulation of AIM2 inflammasome complex assembly At A Glance
| GO ID | GO:0140973 |
|---|---|
| GO term | positive regulation of AIM2 inflammasome complex assembly |
| Ontology | biological_process |
| Synonym | none |
| Major function | Enhances the assembly of the AIM2 inflammasome complex, leading to caspase-1 activation and IL-1beta/IL-18 maturation |
| Related process | Innate immune response to cytosolic DNA |
| Key regulator example | NCF4 negatively regulates inflammasome activation, thereby modulating AIM2 complex assembly |
| Disease relevance | Colorectal cancer, inflammatory disorders, and infections |
| Modulation by immune complexes | Immune complexes can inhibit IL-1 secretion and inflammasome activation |
What Is GO:0140973?
GO:0140973 is defined as any process that activates or increases the frequency, rate or extent of AIM2 inflammasome complex assembly. In other words, it encompasses molecular events that promote the nucleation, oligomerization, and stabilization of the AIM2 inflammasome, a cytosolic sensor complex that detects dsDNA and initiates inflammatory signaling.
Why Is positive regulation of AIM2 inflammasome complex assembly Important in Cell Biology?
Positive regulation of AIM2 inflammasome complex assembly is a critical control point in innate immunity because it determines the magnitude and duration of inflammatory responses to cytosolic DNA. This process is essential for host defense against pathogens such as Francisella tularensis and for antitumor immunity, but its dysregulation can lead to chronic inflammation, autoimmunity, and cancer progression. Understanding the molecular players that enhance AIM2 inflammasome assembly may reveal therapeutic targets for modulating inflammation and improving cancer immunotherapy.
• Enables rapid detection of cytosolic DNA from invading pathogens or damaged host cells.
• Drives caspase-1 activation and the release of pro-inflammatory cytokines IL-1beta and IL-18.
• Promotes pyroptosis, a form of lytic cell death that limits pathogen replication.
• Contributes to immune surveillance of tumors, as shown in colorectal cancer models.
• Is subject to negative regulation by NCF4, preventing excessive inflammation.
• Can be inhibited by immune complexes, linking adaptive immunity to innate inflammasome control.
• Represents a potential target for anti-inflammatory therapies.
• May influence the efficacy of cancer immunotherapies that rely on IL-1beta signaling.
What Happens During positive regulation of AIM2 inflammasome complex assembly?
Recognition of Cytosolic DNA by AIM2
In simple terms: AIM2 acts like a security guard that spots DNA in the wrong place, the cytosol.
AIM2 (absent in melanoma 2) is a cytosolic sensor that binds directly to double-stranded DNA (dsDNA) through its HIN domain. Upon binding, AIM2 undergoes a conformational change that exposes its pyrin domain (PYD), which is necessary for downstream oligomerization. This initial recognition step is the first committed step toward inflammasome assembly and is positively regulated by factors that increase AIM2's affinity for DNA or its availability in the cytosol.
Nucleation and Oligomerization of AIM2
In simple terms: Multiple AIM2 molecules cluster together around DNA to form a platform.
After DNA binding, AIM2 molecules oligomerize via PYD-PYD interactions, forming a nucleation seed that recruits the adaptor protein ASC (apoptosis-associated speck-like protein containing a CARD). Positive regulation of this step can occur through post-translational modifications or accessory proteins that stabilize the AIM2 oligomer. The oligomerization is essential for creating a high-avidity platform for ASC recruitment.
ASC Speck Formation and Caspase-1 Recruitment
In simple terms: ASC forms a large speck that acts as a molecular magnet for caspase-1.
ASC binds to AIM2 via PYD-PYD interactions and then self-associates into large helical filaments, forming a single supramolecular speck per cell. This ASC speck recruits pro-caspase-1 through CARD-CARD interactions, leading to caspase-1 activation. Positive regulation of AIM2 inflammasome assembly enhances ASC speck formation, thereby amplifying caspase-1 activation and downstream cytokine maturation.
Caspase-1 Activation and Cytokine Processing
In simple terms: Caspase-1 becomes an active enzyme that cuts pro-IL-1beta and pro-IL-18 into their active forms.
Once recruited to the ASC speck, pro-caspase-1 undergoes proximity-induced autoactivation. Active caspase-1 cleaves pro-IL-1beta and pro-IL-18 into their mature, secreted forms and also cleaves gasdermin D to induce pyroptosis. Positive regulation of AIM2 inflammasome assembly increases the amount of active caspase-1, thereby boosting cytokine release and cell death.
Modulation by NCF4 and Immune Complexes
In simple terms: Other proteins and signals can put the brakes on the inflammasome.
NCF4 (neutrophil cytosolic factor 4) has been shown to attenuate inflammasome activation and immune surveillance in colorectal cancer, acting as a negative regulator of AIM2 inflammasome assembly. Conversely, immune complexes can inhibit IL-1 secretion and inflammasome activation, indicating that extracellular signals can suppress AIM2-dependent pathways. These findings highlight that positive regulation of AIM2 inflammasome assembly is balanced by inhibitory mechanisms to prevent excessive inflammation [1,2].
Key Genes Involved in GO:0140973 positive regulation of AIM2 inflammasome complex assembly
The following genes and proteins are central to the positive regulation of AIM2 inflammasome complex assembly, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| AIM2 | Cytosolic dsDNA sensor; nucleates inflammasome assembly | Core component; knockout models used to study inflammasome-dependent inflammation |
| ASC (PYCARD) | Adaptor protein; forms specks and recruits caspase-1 | Essential for AIM2 inflammasome assembly; knockout blocks IL-1beta processing |
| Caspase-1 (CASP1) | Effector protease; cleaves IL-1beta, IL-18, and gasdermin D | Knockout abolishes cytokine maturation and pyroptosis |
| NCF4 | Negative regulator of inflammasome activation | Overexpression attenuates AIM2 inflammasome assembly and tumor progression |
| IL-1beta (IL1B) | Pro-inflammatory cytokine processed by caspase-1 | Readout of AIM2 inflammasome activity; knockout mice lack IL-1beta-mediated inflammation |
| IL-18 (IL18) | Pro-inflammatory cytokine processed by caspase-1 | Marker of inflammasome activation; involved in antitumor immunity |
| Gasdermin D (GSDMD) | Pore-forming protein; executes pyroptosis | Knockout prevents pyroptosis downstream of AIM2 inflammasome |
| TBK1 | Kinase that can regulate inflammasome assembly | Potential positive regulator; studied in innate immune signaling |
| IKKepsilon | Kinase involved in interferon signaling | May modulate AIM2 inflammasome activation |
| STING | Adaptor in cytosolic DNA sensing | Crosstalk with AIM2 pathways; knockout affects DNA-induced inflammation |
| cGAS | Cytosolic DNA sensor producing cGAMP | Indirectly influences AIM2 inflammasome via type I interferon |
| NLRP3 | Related inflammasome sensor | Comparative studies; knockout distinguishes AIM2 vs NLRP3 pathways |
| NLRC4 | Related inflammasome sensor | Comparative studies; knockout distinguishes AIM2 vs NLRC4 pathways |
| AIM2 isoforms | Splice variants with altered DNA binding | Overexpression studies to dissect positive regulation |
| POP1 | Pyrin-only protein; inhibits inflammasome assembly | Overexpression blocks AIM2 inflammasome; negative regulator |
| POP2 | Pyrin-only protein; inhibits inflammasome assembly | Overexpression blocks AIM2 inflammasome; negative regulator |
| CARD-only proteins (COPs) | Inhibit caspase-1 recruitment | Overexpression studies to test positive regulation |
How Is positive regulation of AIM2 inflammasome complex assembly Regulated?
Positive regulation of AIM2 inflammasome complex assembly is controlled at multiple levels. NCF4 acts as a negative regulator, attenuating inflammasome activation and immune surveillance in colorectal cancer. Immune complexes can inhibit IL-1 secretion and inflammasome activation, providing an extracellular brake on AIM2-dependent pathways. Additionally, post-translational modifications such as phosphorylation and ubiquitination can modulate AIM2 oligomerization and ASC speck formation. These regulatory mechanisms ensure that AIM2 inflammasome assembly is tightly controlled to prevent excessive inflammation.
positive regulation of AIM2 inflammasome complex assembly and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NCF4 | Colorectal cancer; negative regulator of inflammasome | NCF4 knockout and overexpression in colon cancer cell lines |
| AIM2 | Inflammatory disorders; host defense | AIM2 knockout mice and macrophages |
| IL1B | Autoinflammatory diseases; cancer | IL-1beta reporter mice; knockout |
| GSDMD | Pyroptosis-related inflammation | GSDMD knockout macrophages |
| ASC (PYCARD) | Inflammasome-associated diseases | ASC knockout mice; reconstitution with tagged ASC |
Colorectal Cancer
NCF4 attenuates colorectal cancer progression by modulating inflammasome activation and immune surveillance. Loss of NCF4 leads to enhanced AIM2 inflammasome assembly, increased IL-1beta secretion, and altered tumor microenvironment, suggesting that positive regulation of AIM2 inflammasome assembly can influence cancer outcomes.
Inflammatory and Autoimmune Diseases
Dysregulated AIM2 inflammasome activation contributes to chronic inflammatory and autoimmune conditions. Excessive positive regulation of AIM2 inflammasome assembly can lead to uncontrolled IL-1beta and IL-18 release, driving tissue damage. Conversely, immune complexes can inhibit IL-1 secretion and inflammasome activation, highlighting a potential therapeutic avenue.
Infectious Diseases
AIM2 inflammasome assembly is critical for host defense against intracellular pathogens such as Francisella tularensis and cytomegalovirus. Positive regulation of this process enhances pathogen clearance but must be balanced to avoid immunopathology.
From positive regulation of AIM2 inflammasome complex assembly-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X positively regulate AIM2 inflammasome assembly? | Knockout of gene X in macrophages followed by dsDNA stimulation and ASC speck imaging |
| Does a point mutation in AIM2 affect inflammasome assembly? | Point-mutation knock-in of AIM2 in cell lines |
| Does NCF4 overexpression alter AIM2 inflammasome activation? | Overexpression of NCF4 in colorectal cancer cells |
| How does immune complex exposure affect AIM2 inflammasome assembly? | Immune complex treatment of macrophages followed by IL-1beta ELISA |
| Can we visualize AIM2 inflammasome assembly in real time? | Tagged knock-in of AIM2 or ASC with fluorescent protein |
| What is the role of caspase-1 in AIM2-dependent pyroptosis? | Caspase-1 knockout cells reconstituted with wild-type or mutant caspase-1 |
How to Study the positive regulation of AIM2 inflammasome complex assembly Process
| Method | What It Measures | Typical Application |
|---|---|---|
| ASC speck imaging | Inflammasome assembly | Quantify positive regulation in macrophages |
| IL-1beta ELISA | Caspase-1 activity | Functional readout of AIM2 inflammasome |
| IL-18 ELISA | Caspase-1 activity | Functional readout of AIM2 inflammasome |
| Western blot for caspase-1 | Caspase-1 cleavage | Confirm inflammasome activation |
| CRISPR knockout screen | Identification of regulators | Discover positive regulators of AIM2 assembly |
| Proximity ligation assay | AIM2-ASC interaction | Visualize assembly intermediates |
| Flow cytometry for pyroptosis | Cell death | Measure gasdermin D pore formation |
| Immune complex treatment assay | Inhibition of IL-1 secretion | Test negative regulation |
ASC Speck Imaging
Fluorescence microscopy of ASC specks is a standard method to assess AIM2 inflammasome assembly. Cells are stimulated with dsDNA, fixed, and stained for ASC, and the percentage of cells with a single ASC speck is quantified. This method directly measures the outcome of positive regulation of AIM2 inflammasome complex assembly.
IL-1beta and IL-18 ELISA
Cytokine secretion is a functional readout of AIM2 inflammasome activation. ELISA for IL-1beta and IL-18 in culture supernatants quantifies caspase-1 activity downstream of AIM2 inflammasome assembly. This method is widely used to test positive regulators.
Western Blot for Caspase-1 Cleavage
Activation of caspase-1 is detected by western blot as a p20 cleavage product. This method confirms that AIM2 inflammasome assembly leads to functional caspase-1 activation.
CRISPR Knockout Screening
Genome-wide CRISPR knockout screens can identify positive regulators of AIM2 inflammasome assembly. Cells are transduced with a sgRNA library, stimulated with dsDNA, and selected for altered IL-1beta secretion or pyroptosis. This approach has the power to uncover novel regulators.
How CRISPR Can Be Used to Study GO:0140973 positive regulation of AIM2 inflammasome complex assembly
Knockout
CRISPR knockout of candidate genes is used to determine whether they are required for positive regulation of AIM2 inflammasome assembly. For example, knockout of NCF4 enhances inflammasome activation, confirming its negative regulatory role. Knockout of AIM2 or ASC abolishes assembly, serving as positive controls.
Point Mutation
Point mutations can be introduced into AIM2 or its regulators to dissect specific domains or residues required for positive regulation. For instance, mutating the PYD domain of AIM2 prevents ASC recruitment and inflammasome assembly. Such models help distinguish between DNA binding and oligomerization steps.
Knock-in
Knock-in of tagged AIM2 or ASC (e.g., fluorescent protein) allows real-time visualization of inflammasome assembly in live cells. This approach is valuable for studying the kinetics of positive regulation. Knock-in of disease-associated mutations can also model human conditions.
Overexpression
Overexpression of candidate positive regulators can enhance AIM2 inflammasome assembly and downstream cytokine release. For example, overexpression of NCF4 attenuates inflammasome activation, confirming its negative role. Overexpression of AIM2 itself can drive spontaneous assembly in some contexts.
How EDITGENE Supports positive regulation of AIM2 inflammasome complex assembly Research
Researchers studying positive regulation of AIM2 inflammasome complex assembly-related genes often need to determine whether a candidate gene is causally involved in enhancing or suppressing inflammasome assembly. EDITGENE provides a comprehensive suite of CRISPR services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of AIM2 inflammasome complex assembly research.
Frequently Asked Questions About positive regulation of AIM2 inflammasome complex assembly
What is GO:0140973?
GO:0140973 is the Gene Ontology term for positive regulation of AIM2 inflammasome complex assembly, describing processes that increase the frequency, rate, or extent of AIM2 inflammasome formation.
What genes are involved in positive regulation of AIM2 inflammasome complex assembly?
Key genes include AIM2, ASC (PYCARD), caspase-1 (CASP1), NCF4, IL-1beta (IL1B), IL-18 (IL18), and gasdermin D (GSDMD).
How is AIM2 inflammasome assembly regulated?
It is positively regulated by factors that enhance AIM2 oligomerization and ASC speck formation, and negatively regulated by proteins such as NCF4 and immune complexes [1,2].
What diseases are associated with AIM2 inflammasome assembly?
Dysregulated AIM2 inflammasome assembly is linked to colorectal cancer, inflammatory disorders, autoimmune diseases, and infections.
What methods are used to study AIM2 inflammasome assembly?
Common methods include ASC speck imaging, IL-1beta ELISA, caspase-1 western blot, and CRISPR knockout screens.
Can CRISPR be used to study AIM2 inflammasome assembly?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect the regulation of AIM2 inflammasome assembly.
What is the role of NCF4 in AIM2 inflammasome assembly?
NCF4 attenuates inflammasome activation and immune surveillance in colorectal cancer, acting as a negative regulator.
Do immune complexes affect AIM2 inflammasome assembly?
Immune complexes can inhibit IL-1 secretion and inflammasome activation, suggesting a suppressive role.
What is the AIM2 inflammasome?
The AIM2 inflammasome is a cytosolic multiprotein complex that detects double-stranded DNA and activates caspase-1 to mature IL-1beta and IL-18.
Why is positive regulation of AIM2 inflammasome assembly important?
It is critical for host defense against pathogens and for antitumor immunity, but must be tightly controlled to avoid excessive inflammation.
Conclusion
Positive regulation of AIM2 inflammasome complex assembly (GO:0140973) is a vital biological process that governs innate immune responses to cytosolic DNA. The interplay between positive regulators and negative regulators such as NCF4 ensures balanced inflammasome activation. Understanding this process has broad implications for infectious diseases, cancer, and inflammatory disorders [1,2]. EDITGENE offers advanced CRISPR tools to study this pathway and accelerate therapeutic development.
References
- 1. Li L et al.. 2024. NCF4 attenuates colorectal cancer progression by modulating inflammasome activation and immune surveillance.. Nat Commun 15(1):5170 PMID: 38886341
- 2. Janczy JR et al.. 2014. Immune complexes inhibit IL-1 secretion and inflammasome activation.. J Immunol 193(10):5190-8 PMID: 25320279
